Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The program is designed for sustainable management, not rapid loss
New England Journal of Medicine (2025) This phase 3b open-label trial provided the first direct head-to-head comparison of tirzepatide and semaglutide for obesity, randomizing 751 adults without diabetes to maximum tolerated doses of tirzepatide (10 or 15mg weekly) or semaglutide (1.7 or 2.4mg weekly) for 72 weeks
Slower Results: Weight loss through lifestyle changes often occurs more gradually, requiring patience and consistency
[3] [14] A common regimen is 500mg taken two to three times daily
US$ 23.11
US$ 26.11
US$ 29.70
US$ 24.10
